Sort
146,196 grants matching “diabetes”
AN IN VIVO APPROACH TO CELL-BASED THERAPY FOR TYPE I DIABETES
$2,362,500Ben Z Stanger · University Of Pennsylvania · DP2 · FY2008 · DK
Amyloid elimination by Hsp104 and substrate-optimized variants
$2,362,500James Shorter · University Of Pennsylvania · DP2 · FY2007 · OD
New Genes and Pathways Involved in Atherosclerosis
$2,362,079Alan Richard Tall · Columbia University Health Sciences · P01 · FY2009 · HL
The Biostatistics Research Center for the Impaired Awareness of Hypoglycemia Consortium
$2,361,429Vernon M. Chinchilli · Pennsylvania State Univ Hershey Med Ctr · U01 · FY2024 · DK
Diabetic Macular Edema Clinical Research Network
$2,361,353Jaeb Center For Health Research, Inc. · U10 · FY2002 · EY
Diverse Roles of Reactive Oxygen Species and Inflammation in Vascular Disease
$2,360,539Kathy K Griendling · Emory University · P01 · FY2009 · HL
Triglycerides, Diabetes and Cardiovascular Disease
$2,360,354Karin E. Bornfeldt · University Of Washington · P01 · FY2022 · HL
Long-term impact of random assignment to intensive lifestyle intervention on Alzheimers disease and related dementias: The Action for Health in Diabetes ADRD Study (Look AHEAD-MIND)
$2,359,595Mark Andrew Espeland · Wake Forest University Health Sciences · R01 · FY2018 · AG
Hearing Impairment in Long-Term Type 1 Diabetes
$2,357,551Rose A Gubitosi-Klug · Case Western Reserve University · DP3 · FY2013 · DK
Harnessing Mindset in 21st Century Healthcare
$2,355,000Alia Crum · Stanford University · DP2 · FY2016 · AT
Genetically encoded tools for manipulation of metabolism in vivo
$2,355,000Denis Vasilievich Titov · University Of California Berkeley · DP2 · FY2018 · GM
Hyperglycemia and Adverse Pregnancy Outcome (HAPO)
$2,354,670Boyd E Metzger · Northwestern University At Chicago · R01 · FY2006 · HD
Mechanisms and biological consequences of the nuclear receptor CAR activation
$2,354,481Masahiko Negishi · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES
Epidemiologic studies of maternal and early life metabolic risk
$2,354,322Madhumita Sinha · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Chromatin Structure and Gene Expression
$2,354,112Gordon L Hager · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
The Fragile Families Cardiovascular Health Follow Up Study
$2,354,049Daniel A Notterman · Princeton University · R01 · FY2020 · HL
HYPERGLYCEMIA AND ADVERSE PREGNANCY OUTCOME
$2,353,615Northwestern University · R01 · FY2001 · HD
Mitigating Diabetic Ketoacidosis in People with T1D and Chronic Kidney Disease on an SGLT1&2 Inhibitor: Ketosis Risk Factor Determination and Incorporation into an Enhanced Glucose Ketone Report
$2,352,906Richard Mauritz Bergenstal · Healthpartners Institute · U01 · FY2025 · DK
Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP Maternal Follow-up Study)
$2,352,905Alan Thevenet N. Tita · University Of Alabama At Birmingham · R01 · FY2021 · HL
New Molecules in Triglyceride Metabolism and Adipogenesis
$2,352,632Stephen G Young · University Of California Los Angeles · P01 · FY2014 · HL
Mechanisms and biological consequences of the nuclear receptor CAR activation
$2,352,234Masahiko Negishi · National Institute Of Environmental Health Sciences · ZIA · FY2013 · ES
Vascular Consequences of Insulin Resistance and Obesity
$2,351,521Joseph A. Vita · Boston University Medical Campus · P50 · FY2010 · HL
MIT Center for Integrative Synthetic Biology
$2,349,998Ron Weiss · Massachusetts Institute Of Technology · P50 · FY2013 · GM
Support services for the NIDDK Epidemiology Coordinating Committee
$2,349,467Social And Scientific Systems, Inc. · N01 · FY2019 · HD
AI-ADRD: Accelerating interventions of AD/ADRD via Machine learning methods
$2,348,869Yong Chen · University Of Pennsylvania · RF1 · FY2023 · AG